Núria Montserrat in a feature article at the ERC’s covid-19 section: Stopping coronavirus at the gate
Search Results for:
Research4Talent
On Wednesday 20th May we’ll open our doors virtually to UNDERGRADUATE & MASTER’s students interested in a research career The day is a chance for you to talk to our … Read more
The research with organoids against COVID19 reaches the international press
One of the most prestigious German newspapers, the Süddeutsche Zeitung echoes the work of Núria Montserrat and her international partners who are investigating with organoids a drug that blocks the entrance door of Covid19.
PeriCord, a bioimplant for infarcted hearts
The journal “EBioMedicine” of “The Lancet” has just published the procedure that allowed the creation, last year, of the “PeriCord”, the first human cardiac bioimplant, in which development the Institute for Bioengineering of Catalonia (IBEC) played a key role.
The journal “EBioMedicine” of “The Lancet” has just published the procedure that allowed the creation, last year, of the “PeriCord”, the first human cardiac bioimplant, in which development the Institute for Bioengineering of Catalonia (IBEC) played a key role. In May 2019, a collaboration between the ‘Germans Trias i Pujol’ Hospital, the Blood and Tissue Bank (BST) and IBEC took a step forward for heart patients combining medicine, science and engineering.
Bioengineering contributes to new advances against childhood cancer
IBEC contributes to elucidate how the rigidity of the tumor extracellular matrix affects the aggressiveness of neuroblastoma, a cancerous tumor that affects mainly children. This opens the door to generate more accurate models to predict tumor development in patients and to work in the design of new treatments.
IBEC contributes to elucidate how the rigidity of the tumor extracellular matrix affects the aggressiveness of neuroblastoma, a cancerous tumor that affects mainly children. This opens the door to generate more accurate models to predict tumor development in patients and to work in the design of new treatments. Neuroblastoma is the most frequent malignant tumor in the first year of life. It is caused by a genetic mutation from immature nerve cells (neuroblasts) that the fetus produces as part of its development process.
Newsletter
[newsletter]
Online IBEC Seminar: Elena Martínez
Development of biomimetic models of intestinal tissue: guiding cellular self-organization through biofabrication techniques Elena Martínez , IBEC Epithelial tissues contain three-dimensional (3D) microstructures that guide cell self-organization at the tissue … Read more
Online IBEC Seminar: Samuel Sánchez
BioEngineering Hybrid Robotic Machines: from nanobots to 3D Bioprinted Robots Samuel Sánchez , IBEC The combination of biological components and artificial ones emerges into what we called hybrid machines/bots/robots. Here, … Read more
Fausto, always in our thoughts
IBEC is saddened to announce the decease of Fausto Sanz, founding Group Leader of IBEC and Professor at the University of Barcelona. Professor Sanz took an active part in the creation of the Catalan Reference Center in Biomedical Engineering (CREBEC) and after in 2005, in the birth and development of IBEC as research institute.
Professor Sanz was always an enthusiast scientist and a pioneer in Catalonia in the field of electrochemistry, nanoscience, and the use of tunneling and atomic force microscopies. In memorandum of Professor Sanz, we recall this piece by Vienna Leigh.
Online IBEC Seminar: Lorenzo Albertazzi
A super-resolved look at nanomedicine Lorenzo Albertazzi , IBEC Nanomaterials revolutionized the field of biomedicine introducing innovative approaches towards drug delivery, molecular imaging, regenerative medicine and biosensing. However, despite the … Read more